AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $456,800 | +14.0% | 80,000 | 0.0% | 0.00% | -66.7% |
| Q1 2024 | $400,800 | -45.6% | 80,000 | -2.4% | 0.00% | -50.0% |
| Q4 2023 | $737,180 | +15.7% | 82,000 | 0.0% | 0.01% | 0.0% |
| Q3 2023 | $637,140 | -19.7% | 82,000 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $793,760 | +1.1% | 82,000 | +14.5% | 0.01% | 0.0% |
| Q1 2023 | $784,736 | +220.9% | 71,600 | +26.5% | 0.01% | +250.0% |
| Q4 2022 | $244,512 | +6.3% | 56,600 | +85.0% | 0.00% | -33.3% |
| Q3 2022 | $230,000 | -25.3% | 30,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $308,000 | -4.3% | 30,600 | +17.7% | 0.00% | 0.0% |
| Q1 2022 | $322,000 | -8.0% | 26,000 | +69.9% | 0.00% | 0.0% |
| Q4 2021 | $350,000 | -52.1% | 15,300 | -53.7% | 0.00% | -50.0% |
| Q3 2021 | $731,000 | +70.8% | 33,037 | 0.0% | 0.01% | +50.0% |
| Q2 2021 | $428,000 | -0.2% | 33,037 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $429,000 | -60.6% | 33,037 | -58.0% | 0.00% | -25.0% |
| Q4 2020 | $1,088,000 | – | 78,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 400,434 | $2,655,000 | 1.58% |
| NEA Management Company, LLC | 4,808,483 | $31,928,000 | 1.38% |
| Kazazian Asset Management, LLC | 170,356 | $1,131,000 | 1.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 212,865 | $1,413,000 | 0.99% |
| Vivo Capital, LLC | 1,213,290 | $8,056,000 | 0.81% |
| Polar Capital LLP | 2,811,516 | $18,668,000 | 0.16% |
| Cutler Capital Management, LLC | 55,000 | $254,000 | 0.11% |
| Patriot Financial Group Insurance Agency, LLC | 20,000 | $133,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 77,913 | $517,000 | 0.05% |
| MGO ONE SEVEN LLC | 11,000 | $73,000 | 0.03% |